National Coordination Centre, Pharmcovigilance Programme of India, Indian Pharmacopoeia Commission, Ghaziabad, Uttar Pradesh, India.
Indian J Pharmacol. 2019 Jul-Aug;51(4):236-242. doi: 10.4103/ijp.IJP_595_18.
To improve the public health and promote instant adverse drug reaction (ADR) reporting, a need to develop an ADR Pharmacovigilance Programme of India (PvPI) mobile app was identified by the National Coordination CentrePvPI (NCCPvPI) to serve the Pan India ADR reporting. The objective of this study was to develop an indigenous Googlebased Android mobile application known as "ADR PvPI" and to analyze the ADRrelated data reported through this mobile application on pilot basis.
The ADR PvPI mobile application was indigenously developed by NCCPvPI officials within 6 months. The study of spontaneous ADR reporting was carried out between September 2017 and September 2018. This article provides an overview of the salient features of ADR PvPI mobile application, guides on how to fillin ADRs, reporting trends of ADR, types of ADR as per System Organ Class and pharmacological classes of drugs.
Till date, >5500 users have downloaded the app with an average rating of 4.26. In that tenure, 262 reports have been received through ADR PvPI mobile app. During the year 2017, 3.55% of reports were received through ADR PvPI mobile app and the percentage of reports received by 2018 was 96.45%.
The frequency of ADR reporting has significantly increased over the past 1 year and should be promoted further through awareness and training programs.
为了改善公众健康并促进即时药物不良反应(ADR)报告,国家药品不良反应监测中心(NCCPvPI)确定需要开发印度药品不良反应监测计划(PvPI)移动应用程序,以服务于全印度的 ADR 报告。本研究的目的是开发一种基于本土 Google 的 Android 移动应用程序,称为“ADR PvPI”,并分析通过该移动应用程序报告的与 ADR 相关的数据。
ADR PvPI 移动应用程序由 NCCPvPI 官员在 6 个月内自主开发。ADR 自发报告研究于 2017 年 9 月至 2018 年 9 月进行。本文概述了 ADR PvPI 移动应用程序的显著特点,介绍了如何填写 ADR 报告、ADR 报告趋势、按系统器官分类和药物的药理分类报告的 ADR 类型。
迄今为止,已有>5500 名用户下载了该应用程序,平均评分为 4.26。在此期间,已通过 ADR PvPI 移动应用程序收到 262 份报告。2017 年,通过 ADR PvPI 移动应用程序收到的报告占 3.55%,2018 年收到的报告占 96.45%。
在过去的 1 年中,ADR 报告的频率显著增加,应通过宣传和培训计划进一步推广。